v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended
Mar. 31, 2020
Mar. 31, 2019
Operating Expenses:    
Research and development expenses $ 1,054,609 $ 686,914
General and administrative expenses 1,245,636 1,562,352
Total Operating Expenses 2,300,245 2,249,266
Loss From Operations (2,300,245) (2,249,266)
Other Income (Expense)    
Interest income 23,432 8,378
Warrant modification expense 441,763
Total other income (expense) 23,432 (433,385)
Loss Before Provision For Income Taxes (2,276,813) (2,682,651)
Benefit from income taxes
Net Loss $ (2,276,813) $ (2,682,651)
Net loss per share, basic and diluted $ (0.22) $ (0.33)
Weighted average shares, basic and diluted 10,497,325 8,250,708

Source